These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 22521832)

  • 41. Peroxisomal fatty acid uptake mechanism in Saccharomyces cerevisiae.
    van Roermund CW; Ijlst L; Majczak W; Waterham HR; Folkerts H; Wanders RJ; Hellingwerf KJ
    J Biol Chem; 2012 Jun; 287(24):20144-53. PubMed ID: 22493507
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Thyroid Hormone-Based Strategy for Correcting the Biochemical Abnormality in X-Linked Adrenoleukodystrophy.
    Hartley MD; Kirkemo LL; Banerji T; Scanlan TS
    Endocrinology; 2017 May; 158(5):1328-1338. PubMed ID: 28200172
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Co-expression of mutated and normal adrenoleukodystrophy protein reduces protein function: implications for gene therapy of X-linked adrenoleukodystrophy.
    Unterrainer G; Molzer B; Forss-Petter S; Berger J
    Hum Mol Genet; 2000 Nov; 9(18):2609-16. PubMed ID: 11063720
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Silencing of Abcd1 and Abcd2 genes sensitizes astrocytes for inflammation: implication for X-adrenoleukodystrophy.
    Singh J; Khan M; Singh I
    J Lipid Res; 2009 Jan; 50(1):135-47. PubMed ID: 18723473
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oxidative damage compromises energy metabolism in the axonal degeneration mouse model of X-adrenoleukodystrophy.
    Galino J; Ruiz M; Fourcade S; Schlüter A; López-Erauskin J; Guilera C; Jove M; Naudi A; García-Arumí E; Andreu AL; Starkov AA; Pamplona R; Ferrer I; Portero-Otin M; Pujol A
    Antioxid Redox Signal; 2011 Oct; 15(8):2095-107. PubMed ID: 21453200
    [TBL] [Abstract][Full Text] [Related]  

  • 46. C26:0-Carnitine Is a New Biomarker for X-Linked Adrenoleukodystrophy in Mice and Man.
    van de Beek MC; Dijkstra IM; van Lenthe H; Ofman R; Goldhaber-Pasillas D; Schauer N; Schackmann M; Engelen-Lee JY; Vaz FM; Kulik W; Wanders RJ; Engelen M; Kemp S
    PLoS One; 2016; 11(4):e0154597. PubMed ID: 27124591
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Very long chain fatty acid β-oxidation in astrocytes: contribution of the ABCD1-dependent and -independent pathways.
    Morita M; Shinbo S; Asahi A; Imanaka T
    Biol Pharm Bull; 2012; 35(11):1972-9. PubMed ID: 23123468
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ABC Transporter Subfamily D: Distinct Differences in Behavior between ABCD1-3 and ABCD4 in Subcellular Localization, Function, and Human Disease.
    Kawaguchi K; Morita M
    Biomed Res Int; 2016; 2016():6786245. PubMed ID: 27766264
    [TBL] [Abstract][Full Text] [Related]  

  • 49. X-linked adrenoleukodystrophy: clinical, metabolic, genetic and pathophysiological aspects.
    Kemp S; Berger J; Aubourg P
    Biochim Biophys Acta; 2012 Sep; 1822(9):1465-74. PubMed ID: 22483867
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detection of Characteristic Phosphatidylcholine Containing Very Long Chain Fatty Acids in Cerebrospinal Fluid from Patients with X-Linked Adrenoleukodystrophy.
    Fujitani N; Saito M; Akashi T; Morita M; So T; Oka K
    Biol Pharm Bull; 2022; 45(11):1725-1727. PubMed ID: 36328509
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential substrate specificities of human ABCD1 and ABCD2 in peroxisomal fatty acid β-oxidation.
    van Roermund CW; Visser WF; Ijlst L; Waterham HR; Wanders RJ
    Biochim Biophys Acta; 2011 Mar; 1811(3):148-52. PubMed ID: 21145416
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of family D ATP-binding cassette transporters (ABCD) in cancer.
    Hlaváč V; Souček P
    Biochem Soc Trans; 2015 Oct; 43(5):937-42. PubMed ID: 26517907
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Induced pluripotent stem cell models from X-linked adrenoleukodystrophy patients.
    Jang J; Kang HC; Kim HS; Kim JY; Huh YJ; Kim DS; Yoo JE; Lee JA; Lim B; Lee J; Yoon TM; Park IH; Hwang DY; Daley GQ; Kim DW
    Ann Neurol; 2011 Sep; 70(3):402-9. PubMed ID: 21721033
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [X-linked adrenoleukodystrophy].
    Aubourg P
    Ann Endocrinol (Paris); 2007 Dec; 68(6):403-11. PubMed ID: 17532287
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Very-long-chain fatty acid metabolism in adrenoleukodystrophy protein-deficient mice.
    Yamada T; Shinnoh N; Kondo A; Uchiyama A; Shimozawa N; Kira J; Kobayashi T
    Cell Biochem Biophys; 2000; 32 Spring():239-46. PubMed ID: 11330052
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapeutic potential of deuterium-stabilized (R)-pioglitazone-PXL065-for X-linked adrenoleukodystrophy.
    Monternier PA; Singh J; Parasar P; Theurey P; DeWitt S; Jacques V; Klett E; Kaur N; Nagaraja TN; Moller DE; Hallakou-Bozec S
    J Inherit Metab Dis; 2022 Jul; 45(4):832-847. PubMed ID: 35510808
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CRISPR/Cas9-mediated knockout of Abcd1 and Abcd2 genes in BV-2 cells: novel microglial models for X-linked Adrenoleukodystrophy.
    Raas Q; Gondcaille C; Hamon Y; Leoni V; Caccia C; Ménétrier F; Lizard G; Trompier D; Savary S
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 May; 1864(5):704-714. PubMed ID: 30769094
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adenoassociated virus serotype 9-mediated gene therapy for x-linked adrenoleukodystrophy.
    Gong Y; Mu D; Prabhakar S; Moser A; Musolino P; Ren J; Breakefield XO; Maguire CA; Eichler FS
    Mol Ther; 2015 May; 23(5):824-834. PubMed ID: 25592337
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lack of adrenoleukodystrophy protein enhances oligodendrocyte disturbance and microglia activation in mice with combined Abcd1/Mag deficiency.
    Dumser M; Bauer J; Lassmann H; Berger J; Forss-Petter S
    Acta Neuropathol; 2007 Dec; 114(6):573-86. PubMed ID: 17828604
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Brain microsomal fatty acid elongation is increased in abcd1-deficient mouse during active myelination phase.
    Morita M; Kawamichi M; Shimura Y; Kawaguchi K; Watanabe S; Imanaka T
    Metab Brain Dis; 2015 Dec; 30(6):1359-67. PubMed ID: 26108493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.